POSTPROGRESSION EFFICACY OUTCOMES FROM THE PHASE 3 ARIEL3 STUDY OF RUCAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA ASSOCIATED WITH EITHER BRCA1 OR BRCA2 MUTATIONS Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Weberpals, J.; Oza, A.; Lorusso, D.; Scambia, G.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Clamp, A. R.; Leary, A.; Holloway, R. W.; Amenedo Gancedo, M.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Armstrong, D. K.; Banerjee, S.; Garcia-Donas, J.; Swisher, E. M.; Cameron, T.; Maloney, L.; Goble, S.; Coleman, R. L.; Ledermann, J. A.

authors

Publication Date

  • November 1, 2020

webpage

published in

category

start page

  • A2

end page

  • A3

volume

  • 30